Goldman Sachs’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,853	Closed	-$63K	–	5823
2022 Q2	$63K	Sell	21,853 -13,713	-39%	-$39.5K	﹤0.01%	5231
2022 Q1	$223K	Buy	+35,566	New	+$223K	﹤0.01%	5037